Figure 5.Correlation between neutrophil-related genes (NRGs) cluster subtypes and drug sensitivity. Increased sensitivity of NRGcluster B to 5-fluorouracil (A), cisplatin (B), KRAS (G12C) inhibitor-12 (C), gemcitabine (D), irinotecan (E), oxaliplatin (F), and paclitaxel (G), increased sensitivity of NRGcluster A to selumetinib (H) and trametinib (I).
